Treatment Algorithms and Recommendations for CVD Risk Management, Microvascular Complications and Foot Care and the Pharmacologic Approach to Glycemic Treatment
There is no greater cause of morbidity and mortality in patients with diabetes than atherosclerotic cardiovascular disease (ASCVD). Diabetes is a risk factor for ASCVD as are medical conditions that are common among individuals with type 2 diabetes (T2D). Multiple studies have demonstrated that significant benefits result from controlling cardiovascular (CV) risk factors in this patient population.